(-)-Epigallocatechin gallate selectively inhibits adenosine diphosphate-stimulated human platelet activation: Suppression of heat shock protein 27 phosphorylation via p38 mitogen-activated protein kinase

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1383-1388

  Iida, Yuko ^a   Doi, Tomoaki ^a   Matsushima nishiwaki, Rie ^a   Tokuda, Haruhiko ^a,b   Ogura, Shinji ^a   Kozawa, Osamu ^a   Iida, Hiroki ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

ADP; Epigallocatechin gallate; Heat shock protein 27; p38 mitogen activated protein kinase; Platelet

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; CD40 LIGAND; COLLAGEN; EPIGALLOCATECHIN GALLATE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR AB; RISTOCETIN; CATECHIN; HSPB1 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR AB; TEA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; TEA;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; CATECHIN; CD40 LIGAND; HSP27 HEAT-SHOCK PROTEINS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET-DERIVED GROWTH FACTOR; RISTOCETIN; TEA;

EID: 84905442883     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2389     Document Type: Article

References (26)

1. Jankun J, Selman SH, Swiercz R and Skrzypczak-Jankun E: Why drinking green tea could prevent cancer. Nature 387: 561, 1997. (Pubitemid 27248750)
2. Kang WS, Lim IH, Yuk DY, et al: Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 96: 229-237, 1999.
3. Oyama J, Maeda T, Kouzuma K, et al: Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J 74: 578-588, 2010.
4. Harborne JB and Williams CA: Advances in flavonoid research since 1992. Phytochemistry 55: 418-504, 2000.
5. Ruggeri ZM: The role of von Willebrand factor in thrombus formation. Thromb Res 120: S5-S9, 2007.
6. Berndt MC, Shen Y, Dopheide SM, Gardiner EE and Andrews RK: The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 86: 178-188, 2001. (Pubitemid 32663951)
7. Garcia A, Quinton TM, Dorsam RT, Kunapuli SP: Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Blood 106: 3410-3414, 2005. (Pubitemid 41609175)
8. Jennings LK: Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102: 248-257, 2009.
9. Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK and López JA: Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood 97: 162-168, 2001. (Pubitemid 32061256)
10. Hechler B, Léon C, Vial C, Vigne P, Frelin C, Cazenave JP and Gachet C: The P2Y1 receptor is necessary for adenosine 5′-diphosphate- induced platelet aggregation. Blood 92: 152-159, 1998. (Pubitemid 28303187)
11. Daniel JL, Dangelmaier C et al: Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 82: 1322-1326, 1999.
12. Kato H, Takai S, Matsushima-Nishiwaki R, Adachi S, Minamitani C, Otsuka T, Tokuda H, Akamatsu S, Doi T, Ogura S and Kozawa O: HSP27 phosphorylation is correlated with ADP-induced platelet granule secretion. Arch Biochem Biophys 475: 80-86, 2008.
13. Doi T, Adachi S, Matsushima-Nishiwaki R, Kato H, Enomoto Y, Minamitani C, Otsuka T, Tokuda H, Akamatsu S, Iwama T, Kozawa O and Ogura S: Antithrombin III suppresses ADP-induced platelet granule secretion: inhibition of HSP27 phosphorylation. Arch Biochem Biophys 489: 62-67, 2009.
14. Enomoto Y, Adachi S, Matsushima-Nishiwaki R, Doi T, Niwa M, Akamastu S, Tokuda H, Ogura S, Yoshimura S, Iwama T and Kozawa O: Thromboxane A(2) promotes soluble CD40 ligand release from human platelets. Atherosclerosis 209: 415-421, 2010.
15. Jin YR, Im JH, Park ES, Cho MR, Han XH, Lee JJ, Lim Y, Kim TJ and Yun YP. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. J Cardiovasc Pharmacol 51: 45-54, 2008.
16. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM and Koller BH: Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5: 1199-1202, 1999. (Pubitemid 29474427)
17. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O and Asano T: Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem 66: 946-950, 1996. (Pubitemid 26065890)
18. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
19. Liu J, Pestina TI, Berndt MC, Steward SA, Jackson CW, Gartner TK: The roles of ADP and TXA2 in botrocetin/VWF-induced aggregation of washed platelets. J Thromb Haemost 2: 2213-2222, 2004. (Pubitemid 40185784)
20. Nakahata N: Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 118: 18-35, 2008.
21. Rendu F and Brohard-Bohn B: The platelet release reaction: granules' constituents, secretion and functions. Platelets 12: 261-273, 2001. (Pubitemid 32730513)
22. Heldin CH and Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999. (Pubitemid 29473317)
23. Hermann A, Rauch BH, Braun M, Schrör K and Weber AA: Platelet CD40 ligand (CD40L) - subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 12: 74-82, 2001. (Pubitemid 32281113)
24. André P, Nannizzi-Alaimo L, Prasad SK and Phillips DR: Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106: 896-899, 2002. (Pubitemid 34925319)
25. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G and Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391: 591-594, 1998. (Pubitemid 28157601)
26. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML and CAPTURE Study Investigators: Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348: 1104-1111, 2003.